Ob.Gyn. NewsBlack Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024Breast CancerDiversity in Medicine
Ob.Gyn. NewsTwice-Yearly PrEP Gives ‘Huge’ 100% ProtectionJuly 26, 2024Sexual HealthBusiness of Medicine
Ob.Gyn. NewsGreater Transparency of Oncologists’ Pharma Relationships NeededJuly 22, 2024Practice ManagementPreventive CareBreast CancerDiversity in MedicineGynecologic CancerMixed TopicsBusiness of Medicine
Ob.Gyn. NewsCognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Breast Cancer
Ob.Gyn. NewsPrescribing Epilepsy Meds in Pregnancy: ‘We Can Do Better,’ Experts SayJuly 15, 2024ObstetricsPreventive Care
Ob.Gyn. NewsEribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast Cancer
Ob.Gyn. NewsPFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Breast Cancer
Ob.Gyn. NewsAdjuvant Avelumab Benefits Seen in High Risk, Triple Negative BCJuly 8, 2024Breast Cancer
Ob.Gyn. NewsClinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?July 5, 2024Breast CancerPreventive Care
Ob.Gyn. NewsMUC-1 vaccine associated with notable overall survival rates in breast cancerJune 27, 2024Breast Cancer
